Summit Therapeutics, Inc. (SMMT)
17.28
-0.38
(-2.12%)
USD |
NASDAQ |
Jan 15, 16:00
17.41
+0.14
(+0.78%)
After-Hours: 18:34
Summit Therapeutics Market Cap: 12.86B for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 33.96B |
| Madrigal Pharmaceuticals, Inc. | 11.26B |
| CorMedix, Inc. | 551.92M |
| Travere Therapeutics, Inc. | 2.540B |
| Viridian Therapeutics, Inc. | 3.155B |
Market Cap Related Metrics
| PEG Ratio | -0.0399 |
| Price to Book Value | 66.89 |
| Price | 17.28 |
| Earnings Yield | -7.19% |
| PEGY Ratio | -0.0399 |